Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Anheuser-Busch InBev SA/NV (BUD) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Anheuser-Busch InBev SA/NV (BUD) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for January 17th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 17th:
Rayonier Advanced Materials Inc. (RYAM - Free Report) : This cellulose specialty products company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its next year earnings increasing 25% over the last 60 days.
Rayonier Advanced Materials Inc. Price and Consensus
Rayonier Advanced Materials Inc. price-consensus-chart | Rayonier Advanced Materials Inc. Quote
Rayonier’s shares gained 93.4% over the last three months compared with the S&P 500’s advance of 6.6%. The company possesses a Momentum Scoreof A.
Rayonier Advanced Materials Inc. Price
Rayonier Advanced Materials Inc. price | Rayonier Advanced Materials Inc. Quote
Anheuser-BuschInBev SA/NV (BUD - Free Report) : This maker of alcoholic and non-alcoholic beverages has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3% over the last 60 days.
AnheuserBusch InBev SANV Price and Consensus
AnheuserBusch InBev SANV price-consensus-chart | AnheuserBusch InBev SANV Quote
Anheuser-Busch’s shares gained 29.8% over the last three months compared with the S&P 500’s advance of 6.6%. The company possesses a Momentum Score of A.
AnheuserBusch InBev SANV Price
AnheuserBusch InBev SANV price | AnheuserBusch InBev SANV Quote
Kala Pharmaceuticals, Inc. (KALA - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Kala Pharmaceuticals, Inc. Price and Consensus
Kala Pharmaceuticals, Inc. price-consensus-chart | Kala Pharmaceuticals, Inc. Quote
Kala’s shares gained 46.5% over the last three months compared with the S&P 500’s advance of 6.6%. The company possesses a Momentum Score of A.
Kala Pharmaceuticals, Inc. Price
Kala Pharmaceuticals, Inc. price | Kala Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.